首页> Gastroenterology> No risk of malignancy with biologics in inflammatory bowel disease: is the debate over?

No risk of malignancy with biologics in inflammatory bowel disease: is the debate over?

导出 LinkOut

翻译打印收藏纠错

第一作者： Maneesh,Dave

第一单位： Division of Gastroenterology & Liver Disease, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, Ohio.

作者： Maneesh,Dave ^[1] ; Edward V,Loftus ^[2]

作者单位： Division of Gastroenterology & Liver Disease, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, Ohio. ^[1] Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota. ^[2]

DOI 10.1053/j.gastro.2014.12.020

PMID 25529813

发布时间 2015-01-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览15

Gastroenterology

2015年148卷2期

447-8页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览15

点击下载本期目录封面

Gastroenterology

2015年148卷2期

447-8页

检索历史清除

No risk of malignancy with biologics in inflammatory bowel disease: is the debate over?

Gastroenterology

相似文献

同项目论文

Gastroenterology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

No risk of malignancy with biologics in inflammatory bowel disease: is the debate over?

Gastroenterology

相似文献

同项目论文

Gastroenterology

相关期刊

检索历史清除